{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:21:44Z","timestamp":1793532104479,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009009","name":"Novartis Pharmaceuticals Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.rmed.2025.108628","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:16:26Z","timestamp":1767140186000},"page":"108628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Personalizing the approach for the diagnosis of patients with concomitant Chronic Obstructive Pulmonary Disease and Heart failure"],"prefix":"10.1016","volume":"252","author":[{"given":"Mira","family":"Abou-Rjeili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Farias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8183-4901","authenticated-orcid":false,"given":"Yousof","family":"Mostafavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Giannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bourbeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9859","key":"10.1016\/j.rmed.2025.108628_bib1","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global Burden of disease study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.rmed.2025.108628_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108628_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurjhf\/hfn013","article-title":"Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur. J. Heart Fail."},{"issue":"36","key":"10.1016\/j.rmed.2025.108628_bib4","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1093\/eurheartj\/eht192","article-title":"Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services","volume":"34","author":"Hawkins","year":"2013","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.rmed.2025.108628_bib5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1164\/rccm.201604-0690SO","article-title":"Chronic obstructive pulmonary disease and cardiac diseases. An urgent need for integrated care","volume":"194","author":"Roversi","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"18","key":"10.1016\/j.rmed.2025.108628_bib6","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/eurheartj\/ehi291","article-title":"Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease","volume":"26","author":"Rutten","year":"2005","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.rmed.2025.108628_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1183\/09031936.00044411","article-title":"Unrecognised ventricular dysfunction in COPD","volume":"39","author":"Macchia","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2025.108628_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/2047487316687425","article-title":"Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: evidence from SUSPIRIUM, a multicentre Italian survey","volume":"24","author":"Griffo","year":"2017","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"4","key":"10.1016\/j.rmed.2025.108628_bib9","first-page":"Cd003566","article-title":"Cardioselective beta-blockers for chronic obstructive pulmonary disease","author":"Salpeter","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.rmed.2025.108628_bib10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0002-9343(02)01346-3","article-title":"The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure","volume":"113","author":"Sin","year":"2002","journal-title":"Am. J. Med."},{"issue":"10","key":"10.1016\/j.rmed.2025.108628_bib11","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinternmed.2010.112","article-title":"Beta-blockers May reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease","volume":"170","author":"Rutten","year":"2010","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108628_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/eurjhf\/hfs009","article-title":"Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF","volume":"14","author":"Mentz","year":"2012","journal-title":"Eur. J. Heart Fail."},{"issue":"9","key":"10.1016\/j.rmed.2025.108628_bib13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00392-012-0450-4","article-title":"Impact of chronic obstructive pulmonary disease severity on symptoms and prognosis in patients with systolic heart failure","volume":"101","author":"Arnaudis","year":"2012","journal-title":"Clin. Res. Cardiol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108628_bib14","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1378\/chest.12-0938","article-title":"Cardiovascular disease in COPD: mechanisms","volume":"143","author":"Maclay","year":"2013","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2025.108628_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150586","article-title":"Inflammatory markers and the risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"11","author":"Su","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.rmed.2025.108628_bib16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1164\/rccm.201110-1792OC","article-title":"Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease","volume":"185","author":"Celli","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108628_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/eurjhf\/hft125","article-title":"Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA","volume":"16","author":"Nymo","year":"2014","journal-title":"Eur. J. Heart Fail."},{"issue":"12","key":"10.1016\/j.rmed.2025.108628_bib18","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1016\/j.bbadis.2012.12.014","article-title":"Biomarkers and diagnostics in heart failure","volume":"1832","author":"Gaggin","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.rmed.2025.108628_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijcard.2013.10.068","article-title":"Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study","volume":"170","author":"Tavazzi","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.rmed.2025.108628_bib20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ijcard.2016.07.109","article-title":"Brain natriuretic peptide: much more than a biomarker","volume":"221","author":"Calzetta","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"10","key":"10.1016\/j.rmed.2025.108628_bib21","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jacc.2003.05.011","article-title":"Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial","volume":"42","author":"Wright","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108628_bib22","first-page":"198","article-title":"Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department","volume":"10","author":"McCullough","year":"2003","journal-title":"Acad. Emerg. Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108628_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.trsl.2013.05.001","article-title":"Chronic obstructive pulmonary disease and cardiovascular disease","volume":"162","author":"Bhatt","year":"2013","journal-title":"Transl. Res."},{"issue":"2","key":"10.1016\/j.rmed.2025.108628_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0735-1097(97)00494-4","article-title":"Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure","volume":"31","author":"Tsutamoto","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108628_bib25","first-page":"212","article-title":"Elevation of cardiac troponins in exacerbation of chronic obstructive pulmonary disease","volume":"16","author":"Harvey","year":"2004","journal-title":"Emerg. Med. Australasia (EMA)"},{"issue":"5","key":"10.1016\/j.rmed.2025.108628_bib26","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1183\/09031936.00158414","article-title":"Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients","volume":"45","author":"Pouwels","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2025.108628_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijcard.2011.01.082","article-title":"S100A8\/A9 complex as a new biomarker in prediction of mortality in elderly patients with severe heart failure","volume":"155","author":"Ma","year":"2012","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108628_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1183\/09031936.00125612","article-title":"Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification","volume":"42","author":"Jones","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108628_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2466-11-42","article-title":"Creating scenarios of the impact of COPD and their relationship to COPD assessment test (CAT\u2122) scores","volume":"11","author":"Jones","year":"2011","journal-title":"BMC Pulm. Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108628_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary","volume":"195","author":"Vogelmeier","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108628_bib31","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00164-2019","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019","volume":"53","author":"Singh","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2025.108628_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir. Med."},{"issue":"11","key":"10.1016\/j.rmed.2025.108628_bib33","first-page":"e596","article-title":"ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"6 Suppl","key":"10.1016\/j.rmed.2025.108628_bib34","doi-asserted-by":"crossref","first-page":"271s","DOI":"10.1378\/chest.122.6_suppl.271S","article-title":"Quantitative assessment of airway remodeling using high-resolution CT","volume":"122","author":"Nakano","year":"2002","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.rmed.2025.108628_bib35","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/eurjhf\/hfp148","article-title":"The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease","volume":"11","author":"Boudestein","year":"2009","journal-title":"Eur. J. Heart Fail."},{"issue":"11","key":"10.1016\/j.rmed.2025.108628_bib36","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10654-006-9066-1","article-title":"Chronic obstructive pulmonary disease severity and cardiovascular outcomes","volume":"21","author":"Curkendall","year":"2006","journal-title":"Eur. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108628_bib37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2003.07.046","article-title":"Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis","volume":"43","author":"Hogg","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108628_bib38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0002-9149(02)03122-3","article-title":"Influence of age on assessment of diastolic function by doppler tissue imaging","volume":"91","author":"Tighe","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.rmed.2025.108628_bib39","article-title":"Differences in outcomes between heart failure phenotypes in patients with coexistent COPD: a cohort study","author":"Gulea","year":"2021","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"11","key":"10.1016\/j.rmed.2025.108628_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005312","article-title":"Cardiac troponin I and risk of cardiac events in patients with heart failure and preserved ejection fraction","volume":"11","author":"Myhre","year":"2018","journal-title":"Circ Heart Fail"},{"issue":"7","key":"10.1016\/j.rmed.2025.108628_bib41","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/thx.2003.019588","article-title":"Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis","volume":"59","author":"Gan","year":"2004","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.rmed.2025.108628_bib42","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108628_bib43","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.rmed.2013.12.014","article-title":"The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients","volume":"108","author":"Lee","year":"2014","journal-title":"Respir. Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125006912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125006912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:42:12Z","timestamp":1773952932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125006912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":43,"alternative-id":["S0954611125006912"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108628","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personalizing the approach for the diagnosis of patients with concomitant Chronic Obstructive Pulmonary Disease and Heart failure","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108628"}}